OPK – opko health, inc. (US:NASDAQ)
Stock Stats
News
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
Greenberg Traurig Advises OPKO Health in $237.5 Million Asset Sale to Labcorp
OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health [Yahoo! Finance]
Form 4 OPKO HEALTH, INC. For: Sep 27 Filed by: FROST PHILLIP MD ET AL
Form 4/A OPKO HEALTH, INC. For: Sep 25 Filed by: FROST PHILLIP MD ET AL
Form 4 OPKO HEALTH, INC. For: Sep 25 Filed by: FROST PHILLIP MD ET AL
Form 8-K OPKO HEALTH, INC. For: Sep 16
Form DEFR14A OPKO HEALTH, INC.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.